| 1. |
MHD 20 : P1 |
including human, animal, plant and microorganism resources for Research & Development aspects, but excluding clinical diagnosis, therapeutics, food production and agriculture. |
20-09-2024 |
20-11-2060 |
9
|
| 2. |
MHD 20 : P2 |
manufacturing and related processes for cells, for cells used for therapeutic purposes, cells used in in-vitro evaluation systems for pharmaceuticals. develops standards regarding manufacturing and related processes for cell-related entities, including exosomes, bacteriophages, and so forth. |
20-09-2024 |
20-11-2060 |
8
|
| 3. |
MHD 20 : P3 |
standardization for accurate, reproducible and robust measurements and analyses in support of biotechnologies relevant molecules and entities, including nucleic acids, proteins, and cells |
20-09-2024 |
20-11-2060 |
9
|
| 4. |
MHD 20 : P4 |
Products, processes, test methods and delivery systems derived from nanotechnology for healthcare applications. |
20-09-2024 |
20-09-2060 |
8
|